フォローフィードコミュニティでトレーダーや投資家とつながりましょう.
包括的なオプション データを調査し、オプション フローで高度なフィルターを使用します.
ターミナル モニターで株式と資産のウォッチリストを整理および監視します
Biotechnology Pharmaceutical Company Selects NewCardio's QTinno for Thorough QT Trial Fully Automated ECG Analysis, Empowered by QTinno, to be...
SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities...
NewCardio Announces Changes in Board of Directors and Executive Management PR Newswire PRINCETON, N.J., Jan. 10, 2012 PRINCETON, N.J., Jan. 10...
Top 3 Clinical Research Organization Selects QTinno for a Phase I Drug Safety Trial Fully Automated ECG Analysis, Empowered by QTinno, will be...
NewCardio Announces Financial Results for its 2011 Third Quarter PR Newswire PRINCETON, N.J., Nov. 15, 2011 PRINCETON, N.J., Nov. 15, 2011...
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q (Mark One) X...
Clinilabs will Conduct Phase 1 Trial Using QTinno® NewCardio Schedules Conference Call for November 15, 2011 to Update Shareholders PR...
Top 5 Global Pharmaceutical Company Selects NewCardio's QTinno for Phase I Drug Safety Trial Fully Automated ECG Analysis, Empowered by QTinno...
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 __________________________ FORM 10-Q/A Amendment No. 1...
U.S. SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 12b-25 NOTIFICATION OF LATE FILING SEC File Number: 333-149166...
ご覧いただいた銘柄が下記のボックス内に表示されますので、過去閲覧した銘柄情報に簡単にアクセスすることができます。
顧客サポート: +44 (0) 203 8794 460 | support@advfn.com
ADVFNのサービスをご利用いただくには、利用規約